ESC 365 - Antithrombotic therapy in TAVI patients without indication for oral anticoagulation.

ESC Professional Premium Access

Antithrombotic therapy in TAVI patients without indication for oral anticoagulation.

Session: What you need to know about antithrombotic therapy in patients after TAVI

Topic: Clinical

Speaker: Professor G. Dangas (New York, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor George Dangas

Mount Sinai Medical Center, New York (United States of America)

18 presentations

0 follower

4 more presentations in this session

Embolic stroke. Ischaemic and bleeding risk in patients undergoing TAVI.

Speaker: Professor D. Capodanno (Catania, IT)

Antithrombotic therapy in TAVI patients with indication for oral anticoagulation.

Speaker: Professor M. Valgimigli (Lugano, CH)

Antithrombotic therapy during TAVI and peri-interventional management of antithrombotic therapy.

Speaker: Doctor M. Joner (Munich, DE)

What you need to know about antithrombotic therapy in patients after TAVI – discussion.

Access the full session

What you need to know about antithrombotic therapy in patients after TAVI

Speakers: Professor G. Dangas, Professor D. Capodanno, Professor M. Valgimigli, Doctor M. Joner

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources